Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-05
1991-08-06
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514369, 548183, 548217, 548224, C07D26354
Patent
active
050378422
ABSTRACT:
A series of 5-(4-[2-substituted benzoxazolylmethoxy]benzyl)oxa- and thiazolidine-2,4-diones as antidiabetic and cholesterol lowering agents.
REFERENCES:
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4550172 (1985-10-01), Musser
patent: 4689336 (1987-08-01), Schnur
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4753956 (1988-06-01), Schnur
patent: 4775687 (1988-10-01), Meguro et al.
patent: 4791125 (1988-12-01), Clark
patent: 4948900 (1990-08-01), Iijima
Daus Donald G.
Lumb J. Trevor
McManus James M.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987347